rs57580125
Positions:
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1
The NM_153033.5(KCTD7):c.493+18_493+21dupAGGA variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.123 in 1,612,412 control chromosomes in the GnomAD database, including 13,706 homozygotes. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.12 ( 1236 hom., cov: 30)
Exomes 𝑓: 0.12 ( 12470 hom. )
Consequence
KCTD7
NM_153033.5 intron
NM_153033.5 intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: -1.11
Genes affected
KCTD7 (HGNC:21957): (potassium channel tetramerization domain containing 7) This gene encodes a member of the potassium channel tetramerization domain-containing protein family. Family members are identified on a structural basis and contain an amino-terminal domain similar to the T1 domain present in the voltage-gated potassium channel. Mutations in this gene have been associated with progressive myoclonic epilepsy-3. Alternative splicing results in multiple transcript variants.[provided by RefSeq, Jan 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -16 ACMG points.
BP6
Variant 7-66638448-C-CAGGA is Benign according to our data. Variant chr7-66638448-C-CAGGA is described in ClinVar as [Benign]. Clinvar id is 262690.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.186 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KCTD7 | NM_153033.5 | c.493+18_493+21dupAGGA | intron_variant | ENST00000639828.2 | NP_694578.1 | |||
KCTD7 | NM_001167961.2 | c.493+18_493+21dupAGGA | intron_variant | NP_001161433.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KCTD7 | ENST00000639828.2 | c.493+18_493+21dupAGGA | intron_variant | 2 | NM_153033.5 | ENSP00000492240.1 | ||||
ENSG00000284461 | ENST00000503687.2 | n.323+18_323+21dupAGGA | intron_variant | 2 | ENSP00000421074.1 |
Frequencies
GnomAD3 genomes AF: 0.119 AC: 18092AN: 151934Hom.: 1230 Cov.: 30
GnomAD3 genomes
AF:
AC:
18092
AN:
151934
Hom.:
Cov.:
30
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.132 AC: 32889AN: 249990Hom.: 2429 AF XY: 0.131 AC XY: 17772AN XY: 135150
GnomAD3 exomes
AF:
AC:
32889
AN:
249990
Hom.:
AF XY:
AC XY:
17772
AN XY:
135150
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.124 AC: 180835AN: 1460360Hom.: 12470 Cov.: 32 AF XY: 0.124 AC XY: 90182AN XY: 726232
GnomAD4 exome
AF:
AC:
180835
AN:
1460360
Hom.:
Cov.:
32
AF XY:
AC XY:
90182
AN XY:
726232
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.119 AC: 18117AN: 152052Hom.: 1236 Cov.: 30 AF XY: 0.124 AC XY: 9242AN XY: 74306
GnomAD4 genome
AF:
AC:
18117
AN:
152052
Hom.:
Cov.:
30
AF XY:
AC XY:
9242
AN XY:
74306
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
589
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:2
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Benign, flagged submission | clinical testing | GeneDx | Jan 29, 2014 | The variant is found in EPILEPSY,INFANT-EPI panel(s). - |
Progressive myoclonic epilepsy type 3 Benign:2
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Aug 19, 2021 | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jan 29, 2016 | - - |
Benign, no assertion criteria provided | clinical testing | Mayo Clinic Laboratories, Mayo Clinic | May 16, 2017 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at